Summary
- Current Price
- As of today, COLL price is $35.39, down -1.64% on
- Current Price All-Time High
- COLL price is currently -30.32% below its historical high of $50.79 set on
- Market Cap
- COLL current market cap is $1B, up +21.84% over the past 365 days
- PE Ratio
- COLL current PE ratio is 17.33
- Revenue
- COLL current annual revenue is $780.57M, up +23.62% year-over-year
- Next Earnings
- The next earnings release for COLL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Collegium Pharmaceutical, Inc. |
| Ticker | NASDAQ: COLL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | collegiumpharma.com |
| Employees | 357 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $35.39 | |
| Price, 1D Change | -1.64% | |
| $1B | ||
| - | ||
| 17.33 | ||
| 0.28 | ||
| $781M | ||
| Revenue, 1Y Change | +23.62% | |
| $1.73 | ||
| EPS, 1Y Change | -6.55% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $1.73 | ||
| EPS Estimate | N/A | $7.76 |
| EPS Est. Change | N/A | +347.56% |
| $780.57M | ||
| Revenue Estimate | N/A | $869.86M |
| Revenue Est. Change | N/A | +11.44% |
| Current Price | $35.39 | |
| Price Target | - | $56.00 |
| Price Tgt. Change | - | +58.24% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.18 | $1.86 | -69.96% | |
| $7.47 | $1.73 | -76.78% | |
| $7.76 | N/A | +347.56% | |
| $7.50 | N/A | +332.56% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $629.18M | $631.45M | +0.36% | |
| $781.48M | $780.57M | -0.12% | |
| $869.86M | N/A | +11.44% | |
| $860.15M | N/A | +10.20% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $35.39 | |
| $39.33 | ||
| $34.80 | ||
| $36.73 | ||
| $35.36 | ||
| $0.17 | ||
| 0.28 | ||
| $1.35 | ||
| 49.13 | ||
| 27.34% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $780.57M | ||
| $1.73 | ||
| $0.00 | ||
| 59.35% | ||
| $187.08M | ||
| 23.97% | ||
| $62.87M | ||
| 8.05% | ||
| $413.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 3.10 | ||
| 1.57 | ||
| 1.48 | ||
| - | ||
| 9 | ||
| 1.06 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 17.33 | ||
| 1.44 | ||
| 3.67 | ||
| 3.92 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $301.68M | ||
| $406.53M | ||
| $1.69B | ||
| $691.41M | ||
| $1.38B | ||
| $440.03M | ||
| $936.43M | ||
| $30.41M | ||
| $10.66M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $717.70M | ||
| $276.17M | ||
| $317.31M | ||
| $284.80M | ||
| $226.07M | ||
| $0.00 | ||
| $29.75M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $329.32M | ||
| -$63.53M | ||
| -$110.25M | ||
| $1.74M | ||
| $327.58M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Barclays | → | |
| Needham | → | |
| Barclays | ||
| Truist Securities | → | |
| HC Wainwright & Co. | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with COLL
FAQ
- What is the ticker symbol for Collegium Pharmaceutical, Inc.?
- The ticker symbol for Collegium Pharmaceutical, Inc. is NASDAQ:COLL
- Does Collegium Pharmaceutical, Inc. pay dividends?
- No, Collegium Pharmaceutical, Inc. does not pay dividends
- What sector is Collegium Pharmaceutical, Inc. in?
- Collegium Pharmaceutical, Inc. is in the Healthcare sector
- What industry is Collegium Pharmaceutical, Inc. in?
- Collegium Pharmaceutical, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Collegium Pharmaceutical, Inc. based in?
- Collegium Pharmaceutical, Inc. is headquartered in United States
- When did Collegium Pharmaceutical, Inc. go public?
- Collegium Pharmaceutical, Inc. initial public offering (IPO) was on May 7, 2015
- Is Collegium Pharmaceutical, Inc. in the S&P 500?
- No, Collegium Pharmaceutical, Inc. is not included in the S&P 500 index
- Is Collegium Pharmaceutical, Inc. in the NASDAQ 100?
- No, Collegium Pharmaceutical, Inc. is not included in the NASDAQ 100 index
- Is Collegium Pharmaceutical, Inc. in the Dow Jones?
- No, Collegium Pharmaceutical, Inc. is not included in the Dow Jones index
- When was Collegium Pharmaceutical, Inc. last earnings report?
- Collegium Pharmaceutical, Inc.'s most recent earnings report was on May 7, 2026
- When does Collegium Pharmaceutical, Inc. report earnings?
- The next expected earnings date for Collegium Pharmaceutical, Inc. is August 6, 2026
Data Sources & References
- COLL Official Website www.collegiumpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1267565/000162828026011992/0001628280-26-011992-index.htm
- COLL Profile on Yahoo Finance finance.yahoo.com/quote/COLL
- COLL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coll